Berlin, Germany
Humedics GmbH, a specialist for real-time and mobile measurement of the individual liver function at the bedside of the patient, today announced the closing of a Series C financing round totaling more than 6.3 million Euro. Humedics’ business model, products and company development has attracted new international investors that will join the current private and public investors.
SUCHE
=============================
Archive
Recent Tweets
-
RT @Maren_Lesche: Super proud of our #VisionHealthPioneers teams! Today, @advosense @MySkills_App and #HERS impressed the jurors @zajctjasa…
-
Check out my latest article: Alzheimer's Disease (AD) and Type 2 Diabetes (T2DM)? https://t.co/ETvgpVR1Gq via @LinkedIn
-
RT @peppermint_vp: Check out my latest article: Let’s overcome procrastination to improve patient safety with digital health https://t.co/…
-
Check out my latest article: Let’s overcome procrastination to improve patient safety with digital health… https://t.co/Z6fmtdSGRd
-
PHARMA and Digital Health: The move from Sanofi away from digital health tech solutions in diabetes is hard to unde… https://t.co/wqnvU9fU4e
-